Please login to the form below

Not currently logged in
Email:
Password:

Brexit and the pharmaceutical industry

News & Analysis: how the UK's departure from the EU will impact pharma and the life sciences sector

Election 2019: Labour tops Tory pledge on NHS spending

Election 2019: Labour tops Tory pledge on NHS spending

The pledge comes as campaigning for the 12 December election gathers steam, and once again the NHS has emerged as a key  battleground for the major parties, second only to Brexit. ... The Liberal Democrats’ health spokeswoman Luciana Berger said the

Latest news

More from news
Approximately 164 fully matching, plus 74 partially matching documents found.

Latest Intelligence

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    The effect of Brexit on the UK’s regenerative medicine sector remains unclear, but the UK has the opportunity to develop an independent framework outside the EU regulatory system to accelerate

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    What impact will Brexit have on the business? The possibility of a no-deal Brexit and the weaker pound are not helpful for attracting key talent, especially from Europe. ... However, we continue to support our staff and are well prepared to deal with any

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Naturally, Brexit is one short- to-medium-term threat, but the industry is even more focused on where the EU is heading in terms of the region’s attractiveness to inward

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    UK biotech can survive Brexit. There are enormous and well-founded concerns about the impact of a no-deal Brexit on the UK life sciences sector, and industry organisations such as ... So I’m less pessimistic about the effect of Brexit on our industry

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    French President Emmanuel Macron is said to be backing the candidacy of Michel Barnier – who of course is currently in charge of the Brexit negotiations with the UK.

More from intelligence
Approximately 19 fully matching, plus 34 partially matching documents found.

Latest from PMHub

  • What are you doing, Dave?

    Hey Siri, find a solution to Brexit.He might be disappointed at the banal tasks to which most AI is being put: labour-saving digital assistants that allow people to turn

  • Pegasus expands Pharma team with senior hires

    Account Director, Ed Sexton, previously led media relations for the UK BioIndustry Association, whose award-winning Brexit campaign represented more than 330 life sciences companies in the UK.

  • GENERATION Z IS FEARFUL FOR THE FUTURE OF UK HEALTH SERVICES, SAYS NEW REPORT

    At the start of a year of expected political and economic uncertainty, Brexit is their biggest worry with two-thirds (59%) believing an exit from Europe will have a negative impact ... Regardless of Brexit, both groups seem concerned about the longevity

  • Givers and Takers Givers and Takers

    Noisy politicians who think Brexit is purely about what the UK wants as opposed to a win/win for everyone, impatient drivers who think their journey is more important than those

  • Artificial Intelligence in Healthcare

    Presently, the looming Brexit saga is casting shadows over the UK’s ability to play host to clinical trials at the frontiers of medical innovation.

More from PMHub
Approximately 5 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan...

Infographics